Washington, United States
The World Health Organization (WHO) is celebrating the emergence of the emergency treatment of Janssen vaccine, one dose, Johnson & Johnson estadounidense pharmaceuticals.
“Every new instrument, safety and efficacy, against covid-19 is one more step in controlling the pandemic”, commented the Director General, Tedros Adhanom Ghebreyesus.
If the OMS is approved by the OMS for the use of a vacancy. The first to receive the Pfizer / BioNTech vaccine and the AstraZeneca plant, it is produced in the plants of this pharmaceutical or what is manufactured by the Serum Institute of India with its permit.
These vacancies require a double dose and the Pfizer alone can be applied at ultra-freezing temperatures.
For its part, the Janssen pharmacy can be maintained in a classic refrigerator.
With this approval, the vaccine can integrate the Covax program, funded by the WHO, the Alliance for Vacancies (GAVI) and the Coalition for Innovation in the Prevention of Epidemics (CEPI), for distributing vacancies to countries through desarrollo.